Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells

Abstract

Androgen signaling influences the development and growth of prostate carcinoma. The transcriptional activity of androgen receptor (AR) is regulated by positive or negative transcriptional cofactors. We report here that PIAS1, PIAS3, and PIASy of the protein inhibitor of activated STAT (PIAS) family, which are expressed in human prostate, display distinct effects on AR-mediated gene activation in prostate cancer cells. While PIAS1 and PIAS3 enhance the transcriptional activity of AR, PIASy acts as a potent inhibitor of AR in prostate cancer cells. The effects of PIAS proteins on AR are competitive. PIASy binds to AR but does not affect the DNA binding activity of AR. An NH2-terminal LXXLL signature motif of PIASy, although not required for PIASy–AR interaction, is essential for the transrepression activity of PIASy. Our results identify PIASy as a transcriptional corepressor of AR and suggest that different PIAS proteins have distinct effects on AR signaling in prostate cancer cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Abreu-Martin MT, Chari A, Palladino AA, Craft NA, Sawyers CL . 1999 Mol. Cell. Biol. 19: 5143–5154

  • Bentel JM, Tilley WD . 1996 J. Endocrinol. 151: 1–11

  • Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K . 1997 Science 278: 1803–1805

  • Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR . 1998 Genes Dev. 12: 3343–3356

  • Darnell Jr JE . 1997 Science 277: 1630–1635

  • Freedman LP . 1999 Cell 97: 5–8

  • Glass CK, Rosenfeld MG . 2000 Genes Dev. 14: 121–141

  • Heery DM, Kalkhoven E, Hoare S, Parker MG . 1997 Nature 387: 733–736

  • Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L . 1996 Mol. Endocrinol. 10: 1167–1177

  • Hu X, Lazar MA . 1999 Nature 402: 93–96

  • Huang W, Shostak Y, Tarr P, Sawyers C, Carey M . 1999 J. Biol. Chem. 274: 25756–25768

  • Khan KD, Shuai K, Lindwall G, Maher SE, Darnell Jr JE, Bothwell AL . 1993 Proc. Natl. Acad. Sci. USA 90: 6806–6810

  • Kokontis JM, Liao S . 1999 Vitam. Horm. 55: 219–307

  • Liao J, Fu Y, Shuai K . 2000 Proc. Natl. Acad. Sci. USA 97: 5267–5272

  • Liu B, Gross M, ten Hoeve J, Shuai K . 2001 Proc. Natl. Acad. Sci. USA 98: 3203–3207

  • Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, Shuai K . 1998 Proc. Natl. Acad. Sci. USA 95: 10626–10631

  • McDonald S, Brive L, Agus DB, Scher HI, Ely KR . 2000 Cancer Res. 60: 2317–2322

  • McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG . 1998 Genes Dev. 12: 3357–3368

  • Moilanen AM, Karvonen U, Poukka H, Yan W, Toppari J, Jeanne OA, Palvimo JJ . 1999 J. Biol. Chem. 274: 3700–3704

  • Nagy L, Kao HY, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM, Schwabe JW . 1999 Genes Dev. 13: 3209–3216

  • Neaear AM, Beaurang PA, Zhou S, Abraham S, Solomon W, Tjian R . 1999 Nature 398: 828–832

  • Parker SL, Tong T, Bolden S, Wingo PA . 1997 CA Cancer J. Clin. 47: 5–27

  • Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, Rosenfeld MG . 1999 Genes Dev. 13: 3198–3208

  • Rachez C, Lemon DB, Suldan Z, Bromleigh V, Gamble M, Neaear AM, Erdjument-Bromage H, Tempst P, Freedman LP . 1999 Nature 398: 824–828

  • Shuai K . 1999 Prog. Biophys. Mol. Biol. 71: 405–422

  • Shuai K . 2000 Oncogene 19: 2638–2644

  • Shuai K, Schindler C, Prezioso VR, Darnell Jr JE . 1992 Science 258: 1808–1812

  • Tan J, Hall SH, Hamil KG, Grossman G, Petrusz P, Liao J, Shuai K, French FS . 2000 Mol. Endocrinol. 14: 14–24

  • Torchia J, Glass C, Rosenfeld MG . 1998 Curr. Opin. Cell. Biol. 10: 373–383

  • Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG . 1997 Nature 387: 677–684

  • Trapman J., Cleutjens KB . 1997 Semin. Cancer Biol. 8: 29–36

Download references

Acknowledgements

We thank C Sawyers for discussion and reading the manuscript; X Rao and M Sohn for technical assistance. B Liu is a Cancer Research Institute fellow. Supported by a grant from the NIH (AI43438).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gross, M., Liu, B., Tan, Ja. et al. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20, 3880–3887 (2001). https://doi.org/10.1038/sj.onc.1204489

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204489

Keywords

This article is cited by

Search

Quick links